|
1
|
Siegel RL, Miller KD and Jemal A: Cancer
statistics, 2019. CA Cancer J Clin. 69:7–34. 2019. View Article : Google Scholar : PubMed/NCBI
|
|
2
|
Bekaii-Saab TS, Ou FS, Ahn DH, Boland PM,
Ciombor KK, Heying EN, Dockter TJ, Jacobs NL, Pasche BC, Cleary JM,
et al: Regorafenib dose-optimisation in patients with refractory
metastatic colorectal cancer (ReDOS): A randomised, multicentre,
open-label, phase 2 study. Lancet Oncol. 20:1070–1082. 2019.
View Article : Google Scholar : PubMed/NCBI
|
|
3
|
Gunjur A: Targeted therapy for BRAF-mutant
colorectal cancer. Lancet Oncol. 20:e6182019. View Article : Google Scholar : PubMed/NCBI
|
|
4
|
Pfeiffer P, Yilmaz M, Möller S, Zitnjak D,
Krogh M, Petersen LN, Poulsen LØ, Winther SB, Thomsen KG and
Qvortrup C: TAS-102 with or without bevacizumab in patients with
chemorefractory metastatic colorectal cancer: An
investigator-initiated, open-label, randomised, phase 2 trial.
Lancet Oncol. 21:412–420. 2020. View Article : Google Scholar : PubMed/NCBI
|
|
5
|
Hu M, Zhou X, Wang Y, Guan K and Huang L:
Relaxin-FOLFOX-IL-12 triple combination therapy engages memory
response and achieves long-term survival in colorectal cancer liver
metastasis. J Control Release. 319:213–221. 2020. View Article : Google Scholar : PubMed/NCBI
|
|
6
|
Huyghe JR, Bien SA, Harrison TA, Kang HM,
Chen S, Schmit SL, Conti DV, Qu C, Jeon J, Edlund CK, et al:
Discovery of common and rare genetic risk variants for colorectal
cancer. Nat Genet. 51:76–87. 2019. View Article : Google Scholar :
|
|
7
|
Chi Y, Wang D, Wang J, Yu W and Yang J:
Long non-coding RNA in the pathogenesis of cancers. Cells.
8:10152019. View Article : Google Scholar :
|
|
8
|
Galamb O, Barták BK, Kalmár A, Nagy ZB,
Szigeti KA, Tulassay Z, Igaz P and Molnár B: Diagnostic and
prognostic potential of tissue and circulating long non-coding RNAs
in colorectal tumors. World J Gastroenterol. 25:5026–5048. 2019.
View Article : Google Scholar : PubMed/NCBI
|
|
9
|
Wei L, Wang X, Lv L, Zheng Y, Zhang N and
Yang M: The emerging role of noncoding RNAs in colorectal cancer
chemoresistance. Cell Oncol (Dordr). 42:757–768. 2019. View Article : Google Scholar
|
|
10
|
Xu M, Xu X, Pan B, Chen X, Lin K, Zeng K,
Liu X, Xu T, Sun L, Qin J, et al: LncRNA SATB2-AS1 inhibits tumor
metastasis and affects the tumor immune cell microenvironment in
colorectal cancer by regulating SATB2. Mol Cancer. 18:1352019.
View Article : Google Scholar : PubMed/NCBI
|
|
11
|
Zhang Y, Chen W, Pan T, Wang H, Zhang Y
and Li C: LBX2-AS1 is activated by ZEB1 and promotes the
development of esophageal squamous cell carcinoma by interacting
with HNRNPC to enhance the stability of ZEB1 and ZEB2 mRNAs.
Biochem Biophys Res Commun. 511:566–572. 2019. View Article : Google Scholar : PubMed/NCBI
|
|
12
|
Tang LX, Su SF, Wan Q, He P, Xhang Y and
Cheng XM: Novel long non-coding RNA LBX2-AS1 indicates poor
prognosis and promotes cell proliferation and metastasis through
notch signaling in non-small cell lung cancer. Eur Rev Med
Pharmacol Sci. 23:7419–7429. 2019.PubMed/NCBI
|
|
13
|
Yang Z, Dong X, Pu M, Yang H, Chang W, Ji
F, Liu T, Wei C, Zhang X and Qiu X: LBX2-AS1/miR-219a-2-3p/FUS/LBX2
positive feedback loop contributes to the proliferation of gastric
cancer. Gastric Cancer. 23:449–463. 2020. View Article : Google Scholar
|
|
14
|
Wang Y, Zhao Y, Zhang X, Zhang A and Ma J:
Long noncoding RNA LBX2-AS1 drives the progression of
hepatocellular carcinoma by sponging microRNA-384 and thereby
positively regulating IRS1 expression. Pathol Res Pract.
216:1529032020. View Article : Google Scholar : PubMed/NCBI
|
|
15
|
Sakai S, Ohhata T, Kitagawa K, Uchida C,
Aoshima T, Niida H, Suzuki T, Inoue Y, Miyazawa K and Kitagawa M:
Long noncoding RNA ELIT-1 acts as a Smad3 cofactor to facilitate
TGFβ/Smad signaling and promote epithelial-mesenchymal transition.
Cancer Res. 79:2821–2838. 2019. View Article : Google Scholar : PubMed/NCBI
|
|
16
|
Wang C, Yang Y, Zhang G, Li J, Wu X, Ma X,
Shan G and Mei Y: Long noncoding RNA EMS connects c-Myc to cell
cycle control and tumorigenesis. Proc Natl Acad Sci USA.
116:14620–14629. 2019. View Article : Google Scholar : PubMed/NCBI
|
|
17
|
Xie JJ, Jiang YY, Jiang Y, Li CQ, Lim MC,
An O, Mayakonda A, Ding LW, Long L, Sun C, et al:
Super-enhancer-driven long non-coding RNA LINC01503, regulated by
TP63, is over-expressed and oncogenic in squamous cell carcinoma.
Gastroenterology. 154:2137–2151.e1. 2018. View Article : Google Scholar : PubMed/NCBI
|
|
18
|
Cheng C, Zhang Z, Cheng F and Shao Z:
Exosomal lncRNA RAMP2-AS1 derived from chondrosarcoma cells
promotes angiogenesis through miR-2355-5p/VEGFR2 axis. Onco Targets
Ther. 13:3291–3301. 2020. View Article : Google Scholar : PubMed/NCBI
|
|
19
|
Li P, Li Y, Dai Y, Wang B, Li L, Jiang B,
Wu P and Xu J: The LncRNA H19/miR-1-3p/CCL2 axis modulates
lipopolysaccharide (LPS) stimulation-induced normal human astrocyte
proliferation and activation. Cytokine. 131:1551062020. View Article : Google Scholar : PubMed/NCBI
|
|
20
|
Zhang Q, Jin X, Shi W, Chen X, Pang W, Yu
X and Yang L: A long non-coding RNA LINC00461-dependent mechanism
underlying breast cancer invasion and migration via the
miR-144-3p/KPNA2 axis. Cancer Cell Int. 20:1372020. View Article : Google Scholar : PubMed/NCBI
|
|
21
|
Cheng Q and Wang L: LncRNA XIST serves as
a ceRNA to regulate the expression of ASF1A, BRWD1M, and PFKFB2 in
kidney transplant acute kidney injury via sponging hsa-miR-212-3p
and hsa-miR-122-5p. Cell Cycle. 19:290–299. 2020. View Article : Google Scholar : PubMed/NCBI
|
|
22
|
Tang Z, Li C, Kang B, Gao G, Li C and
Zhang Z: GEPIA: A web server for cancer and normal gene expression
profiling and interactive analyses. Nucleic Acids Res. 45:W98–W102.
2017. View Article : Google Scholar : PubMed/NCBI
|
|
23
|
Fornes O, Castro-Mondragon JA, Khan A, van
der Lee R, Zhang X, Richmond PA, Modi BP, Correard S, Gheorghe M,
Baranašić D, et al: JASPAR 2020: update of the open-access database
of transcription factor binding profiles. Nucleic Acids Res.
48:D87–D92. 2020.
|
|
24
|
Netanely D, Stern N, Laufer I and Shamir
R: An interactive tool for analyzing clinically-labeled multi-omic
cancer datasets. BMC Bioinformatics. 20:7322019. View Article : Google Scholar
|
|
25
|
Mas-Ponte D, Carlevaro-Fita J, Palumbo E,
Hermoso Pulido T, Guigo R and Johnson R: LncATLAS database for
subcellular localization of long noncoding RNAs. RNA. 23:1080–1087.
2017. View Article : Google Scholar : PubMed/NCBI
|
|
26
|
Cao Z, Pan X, Yang Y, Huang Y and Shen HB:
The lncLocator: A subcellular localization predictor for long
non-coding RNAs based on a stacked ensemble classifier.
Bioinformatics. 34:2185–2194. 2018. View Article : Google Scholar : PubMed/NCBI
|
|
27
|
Li JH, Liu S, Zhou H, Qu LH and Yang JH:
starBase v2.0: Decoding miRNA-ceRNA, miRNA-ncRNA and protein-RNA
interaction networks from large-scale CLIP-Seq data. Nucleic Acids
Res. 42:D92–D97. 2014. View Article : Google Scholar
|
|
28
|
Chandrashekar DS, Bashel B, Balasubramanya
SAH, Creighton CJ, Ponce-Rodriguez I, Chakravarthi BVSK and
Varambally S: UALCAN: A portal for facilitating tumor subgroup gene
expression and survival analyses. Neoplasia. 19:649–658. 2017.
View Article : Google Scholar : PubMed/NCBI
|
|
29
|
Livak KJ and Schmittgen TD: Analysis of
relative gene expression data using real-time quantitative PCR and
the 2(−Delta Delta C(T)) method. Methods. 25:402–408. 2001.
View Article : Google Scholar
|
|
30
|
Xu Z, Zhu C, Chen C, Zong Y, Feng H, Liu
D, Feng W, Zhao J and Lu A: CCL19 suppresses angiogenesis through
promoting miR-206 and inhibiting Met/ERK/Elk-1/HIF-1α/VEGF-A
pathway in colorectal cancer. Cell Death Dis. 9:9742018. View Article : Google Scholar
|
|
31
|
Ma J, Liu X, Chen H, Abbas MK, Yang L, Sun
H, Sun T, Wu B, Yang S and Zhou D: c-KIT-ERK1/2 signaling activated
ELK1 and upregulated carcinoembryonic antigen expression to promote
colorectal cancer progression. Cancer Sci. 112:655–667. 2021.
View Article : Google Scholar
|
|
32
|
Yano S, Wu S, Sakao K and Hou DX:
Involvement of ERK1/2-mediated ELK1/CHOP/DR5 pathway in
6-(methylsulfinyl)hexyl isothiocyanate-induced apoptosis of
colorectal cancer cells. Biosci Biotechnol Biochem. 83:960–969.
2019. View Article : Google Scholar : PubMed/NCBI
|
|
33
|
Kent OA, Mendell JT and Rottapel R:
Transcriptional regulation of miR-31 by oncogenic KRAS mediates
metastatic phenotypes by repressing RASA1. Mol Cancer Res.
14:267–277. 2016. View Article : Google Scholar : PubMed/NCBI
|
|
34
|
Xu G, Zhang Y, Li N, Wu Y, Zhang J, Xu R
and Ming H: LBX2-AS1 up-regulated by NFIC boosts cell proliferation
migration and invasion in gastric cancer through targeting
miR-491-5p/ZNF703. Cancer Cell Int. 20:1362020. View Article : Google Scholar
|
|
35
|
Lu L, Cai M, Peng M, Wang F and Zhai X:
miR-491-5p functions as a tumor suppressor by targeting IGF2 in
colorectal cancer. Cancer Manag Res. 11:1805–1816. 2019. View Article : Google Scholar : PubMed/NCBI
|
|
36
|
Zhang J, Raju GS, Chang DW, Lin SH, Chen Z
and Wu X: Global and targeted circulating microRNA profiling of
colorectal adenoma and colorectal cancer. Cancer. 124:785–796.
2018. View Article : Google Scholar
|
|
37
|
Jung Y, Lee S, Choi HS, Kim SN, Lee E,
Shin Y, Seo J, Kim B, Jung Y, Kim WK, et al: Clinical validation of
colorectal cancer biomarkers identified from bioinformatics
analysis of public expression data. Clin Cancer Res. 17:700–709.
2011. View Article : Google Scholar : PubMed/NCBI
|
|
38
|
Moravkova P, Kohoutova D, Vavrova J and
Bures J: Serum S100A6, S100A8, S100A9 and S100A11 proteins in
colorectal neoplasia: Results of a single centre prospective study.
Scand J Clin Lab Invest. 80:173–178. 2020. View Article : Google Scholar
|
|
39
|
Wang G, Wang X, Wang S, Song H, Sun H,
Yuan W, Cao B, Bai J and Fu S: Colorectal cancer progression
correlates with upregulation of S100A11 expression in tumor
tissues. Int J Colorectal Dis. 23:675–682. 2008. View Article : Google Scholar : PubMed/NCBI
|
|
40
|
Chang Y, Li N, Yuan W, Wang G and Wen J:
LINC00997, a novel long noncoding RNA, contributes to metastasis
via regulation of S100A11 in kidney renal clear cell carcinoma. Int
J Biochem Cell Biol. 116:1055902019. View Article : Google Scholar : PubMed/NCBI
|
|
41
|
Niu Y, Shao Z, Wang H, Yang J, Zhang F,
Luo Y, Xu L, Ding Y and Zhao L: LASP1-S100A11 axis promotes
colorectal cancer aggressiveness by modulating TGFβ/Smad signaling.
Sci Rep. 6:261122016. View Article : Google Scholar
|
